We are live on
!
Find out more
Biogen
BIIB
BIIB
1,104 hedge funds and large institutions have $43.5B invested in Biogen in 2021 Q2 according to their latest regulatory filings, with 136 funds opening new positions, 324 increasing their positions, 468 reducing their positions, and 110 closing their positions.
New
Increased
Maintained
Reduced
Closed
108% more funds holding in top 10
Funds holding in top 10: 13 → 27 (+14)
24% more first-time investments, than exits
New positions opened: 136 | Existing positions closed: 110
22% more capital invested
Capital invested by funds: $35.7B → $43.5B (+$7.81B)
1% more funds holding
Funds holding: 1,093 → 1,104 (+11)
0.17% less ownership
Funds ownership: 83.93% → 83.76% (-0.17%)
6% less call options, than puts
Call options by funds: $1.8B | Put options by funds: $1.91B
31% less repeat investments, than reductions
Existing positions increased: 324 | Existing positions reduced: 468
Holders
1,104
Holders Change
+11
Holders Change %
+1.01%
% of All Funds
19.22%
Holding in Top 10
27
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+107.69%
% of All Funds
0.47%
New
136
Increased
324
Reduced
468
Closed
110
Calls
$1.8B
Puts
$1.91B
Net Calls
-$111M
Net Calls Change
-$185M
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$445M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$148M |
| 3 |
SC
Samlyn Capital
New York
|
+$114M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$101M |
| 5 |
HM
HealthCor Management
New York
|
+$78.4M |
